{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T09:20:55Z","timestamp":1774776055081,"version":"3.50.1"},"reference-count":15,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>During human fulminant hepatic failure (FHF) circulating levels of most hemostatic proteins fall dramatically. Concurrently, factor VIII (fVIII) procoagulant activity rises despite destruction of the hepatocytes considered responsible for fVIII synthesis. This observation suggests a role for cells other than hepatocytes in fVIII biosynthesis during FHF. We have attempted to identify nonhepatocytic sites of fVIII biosynthesis by inducing FHF in mice using acetaminophen overdose, a common cause of human FHF. Acetaminophen-treated mice consistently displayed signs characteristic of FHF, including elevated plasma aminotransferase activity. However, acetaminophen-treated mice demonstrated markedly reduced fVIII activity, contrary to the observation in human FHF. von Willebrand factor antigen levels were only mildly reduced, suggesting that the decrease in fVIII is not secondary to loss of von Willebrand factor. These results imply that there are fundamental differences in the regulation of plasma fVIII levels between humans and mice.<\/jats:p>","DOI":"10.1182\/blood-2003-03-0826","type":"journal-article","created":{"date-parts":[[2003,5,6]],"date-time":"2003-05-06T00:14:56Z","timestamp":1052180096000},"page":"1743-1744","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":7,"title":["Decreased factor VIII levels during acetaminophen-induced murine fulminant hepatic failure"],"prefix":"10.1182","volume":"102","author":[{"given":"Christopher B.","family":"Doering","sequence":"first","affiliation":[{"name":"From the Winship Cancer Institute, Emory University, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest T.","family":"Parker","sequence":"additional","affiliation":[{"name":"From the Winship Cancer Institute, Emory University, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher E.","family":"Nichols","sequence":"additional","affiliation":[{"name":"From the Winship Cancer Institute, Emory University, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pete","family":"Lollar","sequence":"additional","affiliation":[{"name":"From the Winship Cancer Institute, Emory University, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021300262859400_REF1","unstructured":"Kaufman RJ, Pipe SW, Tagliavacca L, Swaroop M, Moussalli M. Biosynthesis, assembly and secretion of coagulation factor VIII. Blood Coagul Fibrinolysis. 1997;8(suppl 2): S3-S14."},{"key":"2020021300262859400_REF2","doi-asserted-by":"crossref","unstructured":"Hollestelle MJ, Thinnes T, Crain K, et al. Tissue distribution of factor VIII gene expression in vivo\u2014a closer look. Thromb Haemost. 2001;86: 855-861.","DOI":"10.1055\/s-0037-1616143"},{"key":"2020021300262859400_REF3","doi-asserted-by":"crossref","unstructured":"Do H, Healey JF, Waller EK, Lollar P. Expression of factor VIII by murine liver sinusoidal endothelial cells. J Biol Chem. 1999;274: 19587-19592.","DOI":"10.1074\/jbc.274.28.19587"},{"key":"2020021300262859400_REF4","doi-asserted-by":"crossref","unstructured":"Hellman L, Smedsro\u0308d B, Sandberg H, Petterson U. Secretion of coagulant factor VIII activity and antigen by in vitro cultivated rat liver sinusoidal endothelial cells. Br J Haematol. 1989; 73: 348-355.","DOI":"10.1111\/j.1365-2141.1989.tb07751.x"},{"key":"2020021300262859400_REF5","doi-asserted-by":"crossref","unstructured":"Bontempo FA, Lewis JH, Gorenc TJ, et al. Liver transplantation in hemophilia A. Blood. 1987;69: 1721-1724.","DOI":"10.1182\/blood.V69.6.1721.1721"},{"key":"2020021300262859400_","doi-asserted-by":"crossref","unstructured":"Scharrer I, Encke A, Hottenrott C. Clinical cure of haemophilia A by liver transplantation. Lancet. 1988;2: 800-801.","DOI":"10.1016\/S0140-6736(88)92456-7"},{"key":"2020021300262859400_REF7","doi-asserted-by":"crossref","unstructured":"Webster WP, Zukoski CF, Hutchin P, Reddick RL, Mandel SR, Penick GD. Plasma factor VIII synthesis and control as revealed by canine organ transplantation. Am J Physiol. 1971;220: 1147-1154.","DOI":"10.1152\/ajplegacy.1971.220.5.1147"},{"key":"2020021300262859400_REF8","doi-asserted-by":"crossref","unstructured":"Baele G, Vermeire P, Demeulenaere L, Barbier F. Elevation of factor VIII in acute liver necrosis. Influence of plasmapheresis. Digestion. 1973;8: 360-367.","DOI":"10.1159\/000197336"},{"key":"2020021300262859400_REF9","doi-asserted-by":"crossref","unstructured":"Langley PG, Hughes RD, Williams R. Increased factor VIII complex in fulminant hepatic failure. Thromb Haemost. 1985;54: 693-696.","DOI":"10.1055\/s-0038-1660099"},{"key":"2020021300262859400_REF10","doi-asserted-by":"crossref","unstructured":"Doering CB, Josephson CD, Craddock HN, Lollar P. Factor VIII expression in azoxymethane-induced murine fulminant hepatic failure. Blood. 2002;100: 143-147.","DOI":"10.1182\/blood.V100.1.143"},{"key":"2020021300262859400_REF11","doi-asserted-by":"crossref","unstructured":"Zhang J, Huang W, Chua SS, Wei P, Moore DD. Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science. 2002;298: 422-424.","DOI":"10.1126\/science.1073502"},{"key":"2020021300262859400_REF12","doi-asserted-by":"crossref","unstructured":"Denis C, Methia N, Frenette PS, et al. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci U S A. 1998;95: 9524-9529.","DOI":"10.1073\/pnas.95.16.9524"},{"key":"2020021300262859400_REF13","doi-asserted-by":"crossref","unstructured":"Tsakiris DA, Scudder L, Hodivala-Dilke K, Hynes RO, Coller BS. Hemostasis in the mouse (Mus musculus): a review. Thromb Haemost. 1999;81: 177-188.","DOI":"10.1055\/s-0037-1614439"},{"key":"2020021300262859400_REF14","doi-asserted-by":"crossref","unstructured":"Doering CB, Parker ET, Healey JF, Craddock HN, Barrow RT, Lollar P. Expression and characterization of recombinant murine factor VIII. Thromb Haemost. 2002;88: 450-458.","DOI":"10.1055\/s-0037-1613237"},{"key":"2020021300262859400_REF15","doi-asserted-by":"crossref","unstructured":"Kamphuisen PW, Eikenboom JC, Bertina RM. Elevated factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol. 2001;21: 731-738.","DOI":"10.1161\/01.ATV.21.5.731"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/102\/5\/1743\/1690243\/h81703001743.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/102\/5\/1743\/1690243\/h81703001743.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T05:26:37Z","timestamp":1581571597000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/102\/5\/1743\/17497\/Decreased-factor-VIII-levels-during"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9,1]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,9,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-03-0826","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9,1]]}}}